Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Gordon William BDirector |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $240K 1,759 sh | Nov 4, 2026 |
| 13 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $846K 4,493 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $35K 662 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $1,165 3 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 109 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $6,599 17 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $97K 700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $182K 1,326 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Gordon William BDirector | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 1,374 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Open-market sale · 10b5-1 plan | SELL | $81K 386 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 80 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $68K 2,257 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $8,146 21 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO |  VRSNVERISIGN INC/CAOpen-market sale · 10b5-1 plan | SELL | $119K 380 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 13 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $2,717 7 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $3,494 9 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Kasbar Michael JDirector, Executive Chairman |  WKCWORLD KINECT CORPOpen-market sale · 10b5-1 plan | SELL | $72K 1,938 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $3.48M 13.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $29K 1,075 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector |  LIFLife360, Inc.Open-market sale · 10b5-1 plan | SELL | $83K 1,841 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $819K 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector | LIFLife360, Inc. Open-market sale · 10b5-1 plan | SELL | $66K 1,433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $1.38M 3,963 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Singh SumitDirector, Chief Executive Officer |  CHWYChewy, Inc.Open-market sale · 10b5-1 plan | SELL | $492K 23.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $1.70M 4,846 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $190K 4,000 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Zuraitis MaritaDirector, President & CEO |  HMNHORACE MANN EDUCATORS CORP /DE/Open-market sale · 10b5-1 plan | SELL | $354K 7,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $50K 1,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $38K 1,025 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | van Houte HansChief Financial Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 1,469 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $75K 1,573 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Clark Joseph GatesSVP and Pres, Optimized LED | PENGPenguin Solutions, Inc. Open-market sale · 10b5-1 plan | SELL | $70K 1,400 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $87K 1,867 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer | INTAIntapp, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 1,200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $235K 5,080 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 11 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $159K 3,172 sh | Nov 4, 2026 traded Nov 4, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K